NCT00977886View on ClinicalTrials.gov

Safety and Pharmacokinetics of ELB353 in Healthy Men

PHASE1CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Healthy Volunteers
Interventions
DRUG

Placebo

Oral, 10 days

DRUG

ELB353

Oral, 10 days

Trial Locations (1)

14050

Biotie investigational site, Berlin

Sponsors
All Listed Sponsors
lead

Biotie Therapies Corp.

INDUSTRY